Similarly, the finding that 85.7% of pancreatic ASC had mutations in the KRAS gene confirms its resemblance to pancreatic adenocarcinoma, where nearly 100% have KRAS mutations38,39. Here, KRAS is linked to pancreatic adenocarcinoma.